Congenital dyserythropoietic anemias

Current Opinion in Hematology

Volumn 18, Issue 3, 2011, Pages 146-151

  Iolascon, Achille ^a,b   Russo, Roberta ^a,b   Delaunay, Jean ^c  

^a CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c INSERM   (France)

Author keywords

congenital dyserythropoietic anemias; SEC23B and KLF1 genes; secondary dyserythropoiesis; syndromic dyserythropoietic anemias

Indexed keywords

TRANSCRIPTION FACTOR GATA 1;

ARTICLE; CDAN1 GENE; CONGENITAL DYSERYTHROPOIETIC ANEMIA; CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE 1; CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE 2; CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE 3; DISEASE CLASSIFICATION; DYSERYTHROPOIESIS; ENDOPLASMIC RETICULUM; GENE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; GOLGI COMPLEX; HUMAN; KLF1 GENE; NONHUMAN; PRIORITY JOURNAL; SEC23B GENE;

ANEMIA, DYSERYTHROPOIETIC, CONGENITAL; ANIMALS; ERYTHROPOIESIS; GENOTYPE; HUMANS; PHENOTYPE;

EID: 79955016823     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32834521b0     Document Type: Article

References (45)

1. Heimpel H, Wendt F. Congenital dyserythropoietic anemia with karyorrhexis and multinuclearity of erythroblasts. Helv Med Acta 1968; 34:103-115.
2. Lavabre-Bertrand T, Ramos J, Delfour C, et al. Long-term alpha interferon treatment is effective on anaemia and significantly reduces iron overload in congenital dyserythropoiesis type I. Eur J Haematol 2004; 73:380-383. (Pubitemid 39349921)
3. Parez N, Dommergues M, Zupan V, et al. Severe congenital dyserythropoietic anaemia type 1: prenatal management, transfusion support and alpha-inter-feron therapy. Br J Haematol 2000; 110:420-423. (Pubitemid 30646870)
4. Heimpel H, Matuschek A, Ahmed M, et al. Frequency of congenital dysery-thropoietic anemias in Europe. Eur J Haematol 2010; 85:20-25.
5. Tamary H, Shalev H, Perez-Avraham G, et al. Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I. Blood 2008; 112:5241-5244.
6. Wickramasinghe SN. Congenital dyserythropoietic anemias. In: Blood and bone marrow pathology. Wickramasinghe SN, McCullough J (editors). Edinburgh: Elsevier -Churchill Livingstone; 2003. pp. 273-282.
7. Tamary H, Shalmon L, Shalev H, et al. Localisation of the gene for congenital dyserythropietic anemia type I to a (Pubitemid 28199006)
8. Dgany O, Avidan N, Delaunay J, et al. Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1.Am J Hum Genet 2002; 71:1467-1474. (Pubitemid 36015901)
9. Noy-Lotan S, Dgany O, Lahmi R, etal. Codanin-1, the protein encoded by the gene mutated in congenital dyserythropoietic anemia type I (CDAN1), is cell cycle regulated. Haematologica 2009; 94:629-637.
10. Tamary H, Dgany O. Congenital dyserythropoietic anemia type I. In Pagon RA, Bird TC, Dolan CR, Stephens K, editors. GeneReviews [online]. Seattle, WA: University of Washington, Seattle; posted Apr 21, 2009.
11. Ahmed MR, Chehal A, Zahed L, et al. Linkage and mutational analysis of the CDAN1 gene reveals genetic heterogeneity in congenital dyserythropoietic anemia type I. Blood 2006; 107:4968-4969. (Pubitemid 43882652)
12. Iolascon A, Delaunay J, Wickramasinghe SN, et al. Natural history of congenital dyserythropoietic anemia (CDA II). Blood 2001; 98:1258-1260.
13. Heimpel H, Anselstetter V, Chrobak L, et al. Congenital dyserythropoietic anemia type II: epidemiology, clinical appearance, and prognosis based on long-term observation. Blood 2003; 102:4576-4581. (Pubitemid 37494127)
14. Remacha AF, Badell I, Pujol-Moix N, et al. Hydrops fetalis associated congenital dyserythropoietic anemia treated with intrauterine transfusions and bone marrow transplantation. Blood 2002; 100:356-358. (Pubitemid 35177471)
15. De Franceschi L, Turrini F, Miraglia del Giudice E, etal. Decreased band 3 anion transport activity and band 3 clusterization in congenital dyserythropoietic anemia type II. Exp Hematol 1998; 26:869-873. (Pubitemid 28350758)
16. Heimpel H, Kellermann K, NeuschwanderN, etal. The morphological diagnosis of congenital dyserythropoietic anemia: results of a quantitative analysis of peripheral blood and bone marrow cells. Haematologica 2010; 95:1034-1036.
17. Alloisio N, Texier P, Denoroy L, etal. The cisternae decorating the red blood cell membrane in congenital dyserythropieitic anemia (type II) originate from the endoplasmic reticulum. Blood 1996; 87:4433-4439. (Pubitemid 26152285)
18. Iolascon I, D'Agostaro G, Perrotta S, et al. Congenital dyserythropoietic anemia type II: molecular basis and clinical aspect. Haematologica 1996; 81:542-558.
19. Denecke J, Marquardt T. Congenital dyserythropoietic anemia type II (CDAII/ HEMPAS): where are we now? Biochim Biophys Acta 2009; 1792:915-920.
20. Gasparini P, Miraglia del Giudice E, Delaunay J, et al. Localization of congenital dyserythropoietic anemia II (CDA II) locus to chromosome 20 (20q11.2) by genomewide search. Am J Hum Genet 1997; 61:1112-1116. (Pubitemid 27492319)
21. Schwarz K, Iolascon A, Verissimo F, et al. Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet 2009; 41:936-940.
22. Bianchi P, Fermo E, Vercellati C, et al. Congenital dyserythropoietic anemia type II (CDA II) is caused by mutations in the SEC23B gene. Hum Mut 2009; 30:1292-1298.
23. Jones B, Jones EL, Bonney SA, et al. Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat Genet 2003; 34:29-31. (Pubitemid 36548786)
24. Boyadjiev SA, Fromme JC, Ben J, et al. Cranio-lenticulo-sutural dysplasia is caused by a SEC23A mutation leading to abnormal endoplasmic-reticulum-to- Golgi trafficking. Nat Genet 2006; 38:1192-1196.
25. Iolascon A, Russo R, Esposito MR, et al. Molecular analysis of forty two CDA II patients: new mutations in the SEC23B gene. Search for a genotype-phenotype relationship. Haematologica 2010; 95:708-715.
26. Russo R, Esposito MR, Asci R, et al. Mutational spectrum in congenital dyserythropoietic anemia type II: identification of 19 novel mutations in SEC23B gene. Am J Hematol 2010; 85:915-920.
27. Iolascon A, Servedio V, Carbone R, etal. Geographic distribution of CDA-II: did a founder effect operate in Southern Italy? Haematologica 2000; 85:470-474. (Pubitemid 30428567)
28. Lind L, Sandstrom H, Wahlin A, et al. Localization of the gene for congenital dyserythropoietic anemia type III, CDAN3, to chromosome 15q21-q25. Hum Mol Genet 1995; 4:109-112.
29. Nichols KE, Crispino JD, Poncz M, et al. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet 2000; 24:266-270. (Pubitemid 30132195)
30. Wickramasinghe SN, Illum N, Wimberley PD. Congenital dyserythropoietic anaemia with novel intra-erythroblastic and intra-erythrocytic inclusions. Br J Haematol 1991; 79:322-330.
31. Tang W, Cai SP, Eng B, et al. Expression of embryonic zeta-globin and epsilon-globin chains in a 10-year-old girl with congenital anemia. Blood 1993; 81:1636-1640. (Pubitemid 23083846)
32. Parsons SF, Jones J, Anstee DJ, et al. A novel form of congenital dyserythropoietic anemia associated with deficiency of erythroid CD44and a unique blood group phenotype [In (a-b-), Co (a-b-)]. Blood 1994; 83:860-868.
33. Agre P, Smith BL, Baumgarten R, etal. Human red cell aquaporin CHIP. II. Expression during normal fetal development and in a novel form of congenital dyserythropoietic anemia. J Clin Invest 1994; 94:1050-1058.
34. Arnaud L, Saison C, Helias V, et al. A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia. Am J Hum Genet 2010; 87:721-727.
35. Singleton BK, Burton NM, Green C, et al. Mutations in EKLF/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype. Blood 2008; 112:2081-2088.
36. Borg J, Papadopoulos P, Georgitsi M, et al. Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat Genet 2010; 42:801-805.
37. Zhou D, Liu K, Sun CW, et al. KLF1 regulates BCL11A expression and 7-to p-globin gene switching. Nat Genet 2010; 42:742-744.
38. Heruth DP, Hawkins T, Logsdon DP, et al. Mutation in erythroid specific transcription factor KLF1 causes hereditary spherocytosis in the Nan hemo lytic anemia mouse model. Genomics 2010; 96:303-307.
39. Siatecka M, Sahr KE, Mezei M, etal. Severe anemia in the Nan mutant mouse caused by sequence-selective disruption of erythroid Kruppel-like factor. Proc Natl Acad Sci USA 2010; 107:15151 -15156T.
40. Majeed HA, El-Shanti H. Majeed syndrome. In Pagon RA, Bird TC, Dolan CR, Stephens K, editors. GeneReviews [online]. Seattle, WA: University of Washington, Seattle; posted Sep 23, 2008.
41. Ferguson PJ, Chen S, Tayeh MK, et al. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet 2005; 42:551-557. (Pubitemid 40993830)
42. Shteyer E, Saada A, Shaag A, et al. Exocrine pancreatic insufficient, dyserythropoietic anemia, and calvarial hyperostosis are caused by a mutation in COX4I2 gene. Am J Hum Genet 2009; 84:412-417.
43. Iolascon A, De Falco L, Borgese F, et al. A novel erythroid anion exchange variant (Gly796Arg) of hereditary stomatocytosis associated with dyserythro-poiesis. Haematologica 2009; 94:1049-1059.
44. Paw BH, Davidson AJ, Zhou Y, et al. Cell-specific mitotic defect and dyserythropoiesis associated with erythroid band 3 deficiency. Nat Genet 2003; 34:59-64. (Pubitemid 36548791)
45. Samkari A, Borzutzky A, Fermo E, et al. A novel missense mutation in MVK associated with MK deficiency and dyserythropoietic anemia. Pediatrics 2010; 125:e964-e968.